SLNO

Soleno Therapeutics, Inc. Common Stock

43.00

USD

SLNO Earnings Reports

Positive Surprise Ratio

SLNO beat 21 of 39 last estimates.

54%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$83.34M

$0.56

Implied change from Q3 25 (Revenue/ EPS)

+26.24%

+19.15%

Implied change from Q4 24 (Revenue/ EPS)

-144.09%

Soleno Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, SLNO reported earnings of 0.47 USD per share (EPS) for Q3 25, beating the estimate of 0.05 USD, resulting in a 759.23% surprise. Revenue reached 66.02 million, compared to an expected 49.06 million, with a 34.58% difference. The market reacted with a -26.59% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 15 analysts forecast an EPS of 0.56 USD, with revenue projected to reach 83.34 million USD, implying an increase of 19.15% EPS, and increase of 26.24% in Revenue from the last quarter.

FAQ

What were Soleno Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Soleno Therapeutics, Inc. Common Stock reported EPS of $0.47, beating estimates by 759.23%, and revenue of $66.02M, 34.58% above expectations.

How did the market react to Soleno Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -26.59%, changed from $63.85 before the earnings release to $46.87 the day after.

When is Soleno Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Soleno Therapeutics, Inc. Common Stock's next earnings report?

Based on 15 analysts, Soleno Therapeutics, Inc. Common Stock is expected to report EPS of $0.56 and revenue of $83.34M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.